The relationship between ABO blood group and the risk of bleeding during vitamin K antagonist treatment

MLA

Andrea A. Garcia, et al. “The Relationship between ABO Blood Group and the Risk of Bleeding during Vitamin K Antagonist Treatment.” Journal of Thrombosis and Haemostasis, vol. 4, June 2006, pp. 1418–20. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....036057b29fa18c9475abf7fa4edf0171&authtype=sso&custid=ns315887.

APA

Andrea A. Garcia, J. F. Van Der Heijden, Pieter H. Reitsma, Joost C. M. Meijers, & F. R. Rosendaal. (2006). The relationship between ABO blood group and the risk of bleeding during vitamin K antagonist treatment. Journal of Thrombosis and Haemostasis, 4, 1418–1420.

Chicago

Andrea A. Garcia, J. F. Van Der Heijden, Pieter H. Reitsma, Joost C. M. Meijers, and F. R. Rosendaal. 2006. “The Relationship between ABO Blood Group and the Risk of Bleeding during Vitamin K Antagonist Treatment.” Journal of Thrombosis and Haemostasis 4 (June): 1418–20. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....036057b29fa18c9475abf7fa4edf0171&authtype=sso&custid=ns315887.